"Full Dose Neoadjuvant FOLFIRINOX is Associated with Prolonged Survival in Patients with Locally Advanced Pancreatic Adenocarcinoma" by Moh'D Khushman

Article

Full Dose Neoadjuvant FOLFIRINOX is Associated with Prolonged Survival in Patients with Locally Advanced Pancreatic Adenocarcinoma

Pancreatology (2015)

Moh'D Khushman, University of Miami
Naomi Dempsey, University of Miami
Jennifer Cudris Maldonado, Pontifical Xavierian University
Arturo Loaiza-Bonilla, University of Pennsylvania
Michel Velez, Memorial Cancer Institute
Lauren Carcas, Florida Cancer Care
Daniel Dammrich, University of Miami
Jorge Hurtado-Cordovi, University of Miami
Ritesh Parajuli, University of Miami
Terri Pollack, University of Miami
Ana P. Harwood, University of Miami
Jessica Macintyre, University of Miami
Ching-Wei David Tzeng, University of Kentucky
Jaime R. Merchan, University of Miami
Maria H. Restrepo, University of Miami
Ikechukwu I. Akunyili, University of Miami
Afonso Ribeiro, University of Miami
Govindarajan Narayanan, University of Miami
Lorraine Portelance, University of Miami
Danny Sleeman, University of Miami
Joe U. Levi, University of Miami
Caio M.S. Rocha Lima, University of Miami
Peter J. Hosein, University of Kentucky

Link

Disciplines

Publication Date

November 1, 2015

DOI

10.1016/j.pan.2015.08.010

Citation Information

Moh'D Khushman, Naomi Dempsey, Jennifer Cudris Maldonado, Arturo Loaiza-Bonilla, et al.. "Full Dose Neoadjuvant FOLFIRINOX is Associated with Prolonged Survival in Patients with Locally Advanced Pancreatic Adenocarcinoma" Pancreatology Vol. 15 Iss. 6 (2015) p. 667 - 673
Available at: http://works.bepress.com/lauren-carcas/4/